Beam Therapeutics Inc. BEAM
509 filings, 3 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 58 events
- Nov 3, 2026 Planned sale Bethany Cavanagh (Senior Vice President, Finance) adopted a 10b5-1 trading planreported in the 10-Q, up to 25,904 shares, runs to Sep 17, 2027
- Nov 3, 2026 8-K Quarterly results8-K item 2.02
- Nov 3, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 16, 2026 Planned sale JOHN M EVANS (Officer, Director) gave notice of a planned sale of 25,000 shares worth about $600KForm 144, approximate sale date Oct 16, 2026, under a 10b5-1 plan adopted Jun 16, 2026
- Oct 15, 2026 Planned sale JOHN M EVANS (Officer, Director) gave notice of a planned sale of 25,000 shares worth about $589KForm 144, approximate sale date Oct 15, 2026, under a 10b5-1 plan adopted Jun 16, 2026
- Aug 4, 2026 Planned sale John Evans (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 200,000 shares, runs to Jun 30, 2027
- Aug 4, 2026 8-K Quarterly results8-K item 2.02
- Aug 4, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 27, 2026 Planned sale AMY SIMON (Officer) gave notice of a planned sale of 16,677 shares worth about $429KForm 144, approximate sale date Jul 27, 2026, under a 10b5-1 plan adopted Mar 27, 2026
- Jun 30, 2026 Planned sale JOHN M EVANS (Officer, Director) gave notice of a planned sale of 25,000 shares worth about $858KForm 144, approximate sale date Jun 30, 2026, under a 10b5-1 plan adopted May 16, 2025
- Jun 29, 2026 Planned sale JOHN M EVANS (Officer, Director) gave notice of a planned sale of 25,000 shares worth about $887KForm 144, approximate sale date Jun 29, 2026, under a 10b5-1 plan adopted May 16, 2025
- Jun 8, 2026 8-K Shareholder vote results8-K item 5.07
- May 7, 2026 Planned sale Amy Simon (Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 296,977 shares, runs to Apr 15, 2027
- May 7, 2026 Planned sale Christine Bellon (Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 10,000 shares, runs to Mar 27, 2027
- May 7, 2026 8-K Quarterly results8-K item 2.02
- May 7, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 14, 2026 Planned sale CAROLE HO (Director) gave notice of a planned sale of 87,784 shares worth about $2.7MForm 144, approximate sale date Apr 14, 2026
- Mar 31, 2026 Planned sale JOHN M EVANS (Officer, Director) gave notice of a planned sale of 25,000 shares worth about $569KForm 144, approximate sale date Mar 31, 2026, under a 10b5-1 plan adopted May 16, 2025
- Mar 31, 2026 Planned sale JOHN M. EVANS (Officer, Director) gave notice of a planned sale of 66,874 shares worth about $1.5MForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted May 19, 2023
- Mar 31, 2026 Planned sale AMY SIMON (Officer) gave notice of a planned sale of 20,000 shares worth about $438KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted May 19, 2023
- Mar 31, 2026 Planned sale GIUSEPPE CIARAMELLA (Officer) gave notice of a planned sale of 26,250 shares worth about $575KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted May 23, 2023
- Mar 31, 2026 Planned sale CHRISTINE BELLON (Officer) gave notice of a planned sale of 20,000 shares worth about $438KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted May 19, 2023
- Mar 30, 2026 Planned sale JOHN M EVANS (Officer, Director) gave notice of a planned sale of 25,000 shares worth about $559KForm 144, approximate sale date Mar 30, 2026, under a 10b5-1 plan adopted May 16, 2025
- Mar 5, 2026 8-K Material agreement ended8-K item 1.02
- Feb 24, 2026 Planned sale GIUSEPPE CIARAMELLA (Officer) gave notice of a planned sale of 35,000 shares worth about $1.1MForm 144, approximate sale date Feb 24, 2026, under a 10b5-1 plan adopted Sep 30, 2025
- Feb 24, 2026 Planned sale Sravan K. Emany (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K
- Feb 24, 2026 8-K Material agreement signed, Quarterly results, New debt or obligation8-K items 1.01, 2.02, 2.03
- Feb 24, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 12, 2026 8-K Material agreement signed8-K item 1.01
- Feb 5, 2026 8-K Director or officer change8-K item 5.02
- Jan 30, 2026 Planned sale JOHN M EVANS (Officer, Director) gave notice of a planned sale of 25,000 shares worth about $709KForm 144, approximate sale date Jan 30, 2026, under a 10b5-1 plan adopted May 16, 2025
- Jan 29, 2026 Planned sale JOHN M EVANS (Officer, Director) gave notice of a planned sale of 25,000 shares worth about $735KForm 144, approximate sale date Jan 29, 2026, under a 10b5-1 plan adopted May 16, 2025
- Jan 22, 2026 Planned sale CHRISTINE BELLON (Officer) gave notice of a planned sale of 1,371 shares worth about $47KForm 144, approximate sale date Jan 22, 2026, under a 10b5-1 plan adopted Sep 16, 2025
- Jan 15, 2026 Planned sale CHRISTINE BELLON (Officer) gave notice of a planned sale of 18,629 shares worth about $645KForm 144, approximate sale date Jan 15, 2026, under a 10b5-1 plan adopted Sep 16, 2025
- Jan 12, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Dec 11, 2025 8-K Acquisition or sale of assets completed8-K item 2.01
- Nov 4, 2025 Planned sale Christine Bellon (Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 20,000 shares, runs to Sep 16, 2026
- Nov 4, 2025 Planned sale Bethany Cavanagh (Senior Vice President, Finance) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,386 shares, runs to Sep 19, 2026
- Nov 4, 2025 Planned sale Giuseppe Ciaramella (President) adopted a 10b5-1 trading planreported in the 10-Q, up to 35,000 shares, runs to Sep 30, 2026
- Nov 4, 2025 8-K Quarterly results8-K item 2.02
- Nov 4, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Aug 5, 2025 Planned sale John Evans (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 200,000 shares, runs to Jun 30, 2026
- Aug 5, 2025 8-K Quarterly results8-K item 2.02
- Aug 5, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 3, 2025 8-K Unregistered share sale8-K item 3.02
- Jun 6, 2025 8-K Shareholder vote results8-K item 5.07
- May 6, 2025 8-K Quarterly results8-K item 2.02
- May 6, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Mar 10, 2025 Offering Sale of 16.2M new shares424B5 · We take no responsibility for, and can provide no assurance as to the reliability of, any information that others may give you. We are offering to sell, and seeking offers to buy, our securities only in jurisdictions where offers and sales are permitted.
- Mar 10, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Mar 10, 2025 8-K Material agreement signed, Other events8-K items 1.01, 8.01
- Feb 25, 2025 Planned sale Amy Simon (Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 204,956 shares, runs to Dec 31, 2025
- Feb 25, 2025 8-K Quarterly results8-K item 2.02
- Feb 25, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Jan 13, 2025 8-K Quarterly results, Regulation FD disclosure, Other events8-K items 2.02, 7.01, 8.01
- Dec 9, 2024 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Dec 6, 2024 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Dec 4, 2024 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 3, 2026 | 10-Q | Quarterly report |
| Nov 3, 2026 | 8-K | Quarterly results |
| Oct 16, 2026 | 144 | Notice of planned insider sale |
| Oct 16, 2026 | 4 | Insider trade |
| Oct 15, 2026 | 144 | Notice of planned insider sale |
| Oct 2, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 4 | Insider trade |
| Aug 14, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 4, 2026 | 10-Q | Quarterly report |
| Aug 4, 2026 | 8-K | Quarterly results |
| Jul 29, 2026 | 4 | Insider trade |
| Jul 27, 2026 | 144 | Notice of planned insider sale |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 1, 2026 | 4 | Insider trade |
| Jun 30, 2026 | 144 | Notice of planned insider sale |
| Jun 29, 2026 | 144 | Notice of planned insider sale |
| Jun 29, 2026 | 4 | Insider trade |
| Jun 22, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 8-K | Shareholder vote results |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| May 7, 2026 | 10-Q | Quarterly report |
| May 7, 2026 | 8-K | Quarterly results |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 17, 2026 | ARS | Annual report to shareholders |
| Apr 17, 2026 | DEFA14A | Extra proxy material |
| Apr 17, 2026 | DEF 14A | Proxy statement |
| Apr 14, 2026 | 144 | Notice of planned insider sale |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 1, 2026 | 4 | Insider trade |
| Mar 31, 2026 | 144 | Notice of planned insider sale |
| Mar 31, 2026 | 144 | Notice of planned insider sale |
| Mar 31, 2026 | 144 | Notice of planned insider sale |
| Mar 31, 2026 | 144 | Notice of planned insider sale |
| Mar 31, 2026 | 144 | Notice of planned insider sale |
| Mar 30, 2026 | 144 | Notice of planned insider sale |
| Mar 26, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 5, 2026 | 8-K | Material agreement ended |
| Feb 26, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 144 | Notice of planned insider sale |
| Feb 24, 2026 | S-8 | Shares registered for employee plans |
| Feb 24, 2026 | 10-K | Annual report |
| Feb 24, 2026 | 8-K | Material agreement signed, Quarterly results, New debt or obligation |
| Feb 12, 2026 | 8-K | Material agreement signed |
| Feb 5, 2026 | 8-K | Director or officer change |
| Feb 5, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 5, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 3, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 2, 2026 | 4 | Insider trade |
| Feb 2, 2026 | 4 | Insider trade |
| Feb 2, 2026 | 4 | Insider trade |
| Feb 2, 2026 | 4 | Insider trade |
| Feb 2, 2026 | 4 | Insider trade |
| Feb 2, 2026 | 4 | Insider trade |
| Jan 30, 2026 | 144 | Notice of planned insider sale |
| Jan 29, 2026 | 144 | Notice of planned insider sale |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 22, 2026 | 144 | Notice of planned insider sale |
| Jan 21, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 15, 2026 | 144 | Notice of planned insider sale |
| Jan 12, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Dec 11, 2025 | 8-K | Acquisition or sale of assets completed |
| Nov 5, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 4, 2025 | 10-Q | Quarterly report |
| Nov 4, 2025 | 8-K | Quarterly results |
| Oct 29, 2025 | 4 | Insider trade |
| Oct 8, 2025 | 4 | Insider trade |
| Oct 3, 2025 | 4 | Insider trade |
| Oct 3, 2025 | 4 | Insider trade |
| Oct 3, 2025 | 4 | Insider trade |
| Oct 2, 2025 | 144 | Notice of planned insider sale |
| Oct 1, 2025 | 144 | Notice of planned insider sale |
| Aug 7, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 6, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 5, 2025 | 10-Q | Quarterly report |
| Aug 5, 2025 | 8-K | Quarterly results |
| Aug 1, 2025 | 4 | Insider trade |
| Jul 3, 2025 | 4 | Insider trade |
| Jul 3, 2025 | 8-K | Unregistered share sale |
| Jun 6, 2025 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BEAM/export.csv") into a cell.